CETIRIZINe (ce-tir'i-zeen) Reactine ![]() Classifications: antihistamine; h1-receptor antagonist; non-sedating; Therapeutic: antihistamine, non-sedating; h1-receptor antagonist Prototype: Loratidine Pregnancy Category: B |
5 mg, 10 mg tablets; 5 mg, 10 mg chewable tablets; 5 mg/5 mL syrup
Cetirizine is a potent H1-receptor antagonist and thus an antihistamine without significant anticholinergic or CNS activity. Low lipophilicity combined with its H1-receptor selectivity probably accounts for its relative lack of anticholinergic and sedative properties.
Effectively treats allergic rhinitis and chronic urticaria by eliminating or reducing the local and systemic effects of histamine release.
Seasonal and perennial allergic rhinitis and chronic idiopathic urticaria.
Hypersensitivity to H1-receptor antihistamines or hydroxyzine; concurrent use of alcohol; hepatic or renal dysfunction; lactation, infants <6 mo.
Moderate to severe renal impairment, pregnancy (category B), children.
Allergic Rhinitis Adult: PO 510 mg once/d Child: PO 25 y, 2.5 mg q.d. (max: 5 mg/d); ≥6 y, 510 mg q.d. Chronic Urticaria Adult: PO 10 mg q.d. or b.i.d. |
Assessment & Drug Effects
Patient & Family Education